Hughes D C, Lee S K, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 9120314 B2, 2017-01-15.
Lee S K, Davis P L, Park J H. "Method for the Synthesis of 13-cis,16-cis,19-cis-Docosatrienoic acid" [P]. US Patent, US 9221268 B2, 2017-04-17.
发明人马晓峰,王建平,刘建华. "A Process for Preparing High-Purity 13-cis,16-cis,19-cis-Docosatrienoic acid" [P]. 中国发明专利, 专利号 CN 110425339 A, 授权公告日 2022-07-15.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2016, 1338, (9), 2168-2181.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2021, 1297, (8), 7403-7411.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 13-cis,16-cis,19-cis-Docosatrienoic acid Using HRMS and NMR". Anal. Methods, 2019, 2467, (11), 3185-3211.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2011, 440, (7), 9491-9498.